⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 1, 2018European Journal of Heart FailureOpen Access

July 2018 at a Glance: Practical Guidance in Acute Heart Failure, Pathophysiology and Clinical Trials of Medical Therapy

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

Marco MetraHeart Failure / Cardiomyopathy

Discussion

Loading...

Member takes

Implication

LVET may aid HF prognostication; review leaves open levosimendan and ultrafiltration roles pending confirmatory trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marco Metra (2018) studied this question.

synapsesocial.com/papers/6a1bf09b4d9126f09c5ed70a https://doi.org/10.1002/ejhf.1006

Topics

HFrEF treatment Heart failure HFpEF management Heart failure hospitalization SGLT2 inhibitors in heart failure

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Direct Comparison of Ultrafiltration to Pharmacological Decongestion in Heart Failure: A Per-Protocol Analysis of CARRESS-HF2018 · 73 citations
2Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes2016 · 103 citations
3Are the Effects of Drugs to Prevent and to Treat Heart Failure Always Concordant? The Statin Paradox and its Implications for Understanding the Actions of Antidiabetic Medications2018 · 15 citations
4Efficacy and Safety of Intermittent Intravenous Outpatient Administration of Levosimendan in Patients With Advanced Heart Failure: The LION-HEART Multicentre Randomised Trial2018 · 190 citations
5A Novel Paradigm for Heart Failure With Preserved Ejection Fraction2013 · 3,579 citations